ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,597Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 337

$677K Total Retail Price of All Prescriptions

Rank: 32 out of 337

624 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 624 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 624 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 12,101 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 738 683 1 1
LISINOPRIL 678 613 2 2
OMEPRAZOLE 655 569 3 4
AMLODIPINE BESYLATE 429 375 4 3
HYDROCHLOROTHIAZIDE 377 357 5 9
ATENOLOL 357 348 6 10
HYDROCODONE-ACETAMINOPHEN 352 304 S3 7 13
LEVOTHYROXINE SODIUM 345 314 8 5
FUROSEMIDE 328 317 9 8
ATORVASTATIN CALCIUM 292 253 10 7
METFORMIN HCL 276 239 11 12
LOVASTATIN 258 258 12 24
LOSARTAN POTASSIUM 238 233 13 15
CITALOPRAM HBR 232 219 14 17
METOPROLOL TARTRATE 195 194 15 6
DONEPEZIL HCL 183 171 16 22
QUINAPRIL HCL 162 150 17 50
FLUTICASONE PROPIONATE 150 128 18 34
METOPROLOL SUCCINATE 142 118 19 21
TRAZODONE HCL 139 102 20 16
DIOVAN 125 121 21 26
FENOFIBRATE 120 98 22 48
CLOZAPINE 117 13 23 94
TAMSULOSIN HCL 116 98 24 25
POLYETHYLENE GLYCOL 3350 115 95 25 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 114 84 26 31
ZOLPIDEM TARTRATE 113 97 27 23
CRESTOR 109 109 28 29
WARFARIN SODIUM 108 94 29 11
GLIMEPIRIDE 106 95 30 55
LIPITOR 99 85 31 33
PANTOPRAZOLE SODIUM 98 78 32 36
SERTRALINE HCL 94 88 33 18
PRAVASTATIN SODIUM 90 89 34 14
HALOPERIDOL 87 87 35 189
GLIPIZIDE ER 87 87 35 69
ZETIA 87 77 35 89
SPIRONOLACTONE 84 84 38 100
TRIAMTERENE-HCTZ 78 78 39 39
MELOXICAM 77 74 40 54
RISPERIDONE 76 74 41 72
FELODIPINE ER 73 65 42 79
QUETIAPINE FUMARATE 72 43 43 61
ALLOPURINOL 71 62 44 28
LOSARTAN-HYDROCHLOROTHIAZIDE 70 59 45 60
TRAMADOL HCL 70 68 45 32
GLIPIZIDE 70 51 45 45
ALENDRONATE SODIUM 68 68 48 19
SPIRIVA 63 63 49 43
CYMBALTA 63 37 49 59
MIRTAZAPINE 62 62 51 27
LABETALOL HCL 60 41 52 149
GLYBURIDE-METFORMIN HCL 59 59 R 53 99
CIPROFLOXACIN HCL 59 54 53 71
RANITIDINE HCL 59 56 53 30
CLOPIDOGREL 58 48 56 42
SYNTHROID 58 58 56 41
DILTIAZEM 24HR ER 58 58 56 76
AMITRIPTYLINE HCL 57 53 R 59 75
BUPROPION XL 56 48 60 306
LEVOXYL 55 44 61 90
BUPROPION HCL SR 53 36 62 154
ISOSORBIDE MONONITRATE ER 51 51 63 70
AZITHROMYCIN 51 45 63 51
HYDRALAZINE HCL 51 51 63 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.